NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
30/06/2026 08:58
NASDAQ TRADE HALT CONTINUESREASON NOT AVAILABLE AT 03:58 AM
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges